DAFNA Capital Management as of March 31, 2021
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 89 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Stereotaxis Com New (STXS) | 21.8 | $92M | 14M | 6.72 | |
| Fate Therapeutics (FATE) | 6.1 | $26M | 314k | 82.45 | |
| Blueprint Medicines (BPMC) | 4.8 | $20M | 208k | 97.23 | |
| Dicerna Pharmaceuticals | 3.6 | $15M | 588k | 25.57 | |
| Sage Therapeutics (SAGE) | 3.2 | $14M | 181k | 74.85 | |
| Morphic Hldg (MORF) | 2.7 | $12M | 182k | 63.28 | |
| Nurix Therapeutics (NRIX) | 2.3 | $9.5M | 306k | 31.09 | |
| AtriCure (ATRC) | 2.0 | $8.4M | 129k | 65.52 | |
| Affimed Therapeutics B V | 1.9 | $7.8M | 990k | 7.91 | |
| Ideaya Biosciences (IDYA) | 1.8 | $7.8M | 332k | 23.50 | |
| Dex (DXCM) | 1.8 | $7.6M | 21k | 359.40 | |
| Xenon Pharmaceuticals (XENE) | 1.7 | $7.3M | 407k | 17.90 | |
| Proqr Therapeutics N V Shs Euro (PRQR) | 1.7 | $7.3M | 1.1M | 6.61 | |
| Neurocrine Biosciences (NBIX) | 1.7 | $7.2M | 74k | 97.25 | |
| Revolution Medicines (RVMD) | 1.6 | $6.9M | 151k | 45.88 | |
| Biohaven Pharmaceutical Holding | 1.5 | $6.4M | 94k | 68.35 | |
| Ishares Tr Nasdaq Biotech Etf (IBB) | 1.4 | $6.1M | 40k | 150.57 | |
| Galapagos Nv Spon Adr (GLPG) | 1.4 | $5.8M | 75k | 77.09 | |
| Karuna Therapeutics Ord | 1.4 | $5.8M | 48k | 120.23 | |
| Cardiovascular Systems | 1.4 | $5.7M | 150k | 38.34 | |
| Cara Therapeutics (CARA) | 1.3 | $5.7M | 261k | 21.71 | |
| Protalix Biotherapeutics (PLX) | 1.3 | $5.4M | 1.2M | 4.46 | |
| Arena Pharmaceuticals Com New | 1.3 | $5.3M | 77k | 69.39 | |
| Adicet Bio (ACET) | 1.2 | $5.0M | 385k | 13.08 | |
| Aerie Pharmaceuticals | 1.2 | $4.9M | 276k | 17.87 | |
| Luminex Corporation | 1.2 | $4.9M | 154k | 31.90 | |
| Accuray Incorporated (ARAY) | 1.1 | $4.7M | 942k | 4.95 | |
| Hookipa Pharma Inc equity | 1.1 | $4.6M | 344k | 13.45 | |
| Mereo Biopharma Group Ads (MREO) | 1.0 | $4.2M | 1.2M | 3.37 | |
| Radius Health Note 3.000% 9/0 (Principal) | 0.9 | $3.7M | 4.0M | 0.93 | |
| Translate Bio | 0.9 | $3.7M | 225k | 16.49 | |
| Redhill Biopharma Sponsored Ads | 0.8 | $3.3M | 456k | 7.32 | |
| Merus N V (MRUS) | 0.8 | $3.3M | 158k | 20.89 | |
| Neuronetics (STIM) | 0.7 | $3.1M | 254k | 12.37 | |
| Ascendis Pharma A S Sponsored Adr (ASND) | 0.7 | $3.0M | 23k | 128.89 | |
| Fs Development Corp Ii Com Cl A | 0.7 | $3.0M | 300k | 9.96 | |
| Venus Concept | 0.7 | $2.9M | 1.2M | 2.35 | |
| Viking Therapeutics (VKTX) | 0.7 | $2.8M | 447k | 6.33 | |
| Harpoon Therapeutics | 0.6 | $2.7M | 127k | 20.92 | |
| Alector (ALEC) | 0.6 | $2.6M | 128k | 20.14 | |
| 89bio (ETNB) | 0.6 | $2.5M | 106k | 23.68 | |
| Natus Medical | 0.6 | $2.4M | 96k | 25.61 | |
| Inflarx Nv (IFRX) | 0.6 | $2.3M | 600k | 3.90 | |
| Aslan Pharmaceuticals Ads | 0.5 | $2.3M | 678k | 3.35 | |
| Mei Pharma Com New | 0.5 | $2.2M | 646k | 3.43 | |
| Applied Genetic Technol Corp C | 0.5 | $2.2M | 430k | 5.07 | |
| ACADIA Pharmaceuticals (ACAD) | 0.5 | $2.1M | 83k | 25.80 | |
| Phasebio Pharmaceuticals | 0.5 | $2.1M | 603k | 3.46 | |
| Gemini Therapeutics | 0.5 | $2.0M | 150k | 13.55 | |
| Mersana Therapeutics (MRSN) | 0.5 | $2.0M | 124k | 16.18 | |
| Cogent Biosciences (COGT) | 0.5 | $2.0M | 224k | 8.78 | |
| Sutro Biopharma (STRO) | 0.5 | $1.9M | 85k | 22.76 | |
| Apellis Pharmaceuticals (APLS) | 0.5 | $1.9M | 45k | 42.91 | |
| Brainway Sponsored Ads (BWAY) | 0.4 | $1.8M | 200k | 9.03 | |
| Athira Pharma (ATHA) | 0.4 | $1.7M | 92k | 18.40 | |
| Kinnate Biopharma | 0.4 | $1.6M | 53k | 31.16 | |
| Compugen Ord (CGEN) | 0.4 | $1.6M | 189k | 8.59 | |
| Arcus Biosciences Incorporated (RCUS) | 0.4 | $1.6M | 58k | 28.07 | |
| Aerie Pharmaceuticals Note 1.500%10/0 (Principal) | 0.4 | $1.6M | 1.5M | 1.04 | |
| Liquidia Technologies Com New (LQDA) | 0.4 | $1.5M | 575k | 2.69 | |
| Johnson & Johnson (JNJ) | 0.4 | $1.5M | 9.4k | 164.36 | |
| Kadmon Hldgs | 0.4 | $1.5M | 395k | 3.89 | |
| Cymabay Therapeutics | 0.4 | $1.5M | 338k | 4.54 | |
| Kalvista Pharmaceuticals (KALV) | 0.4 | $1.5M | 59k | 25.68 | |
| Infinity Pharmaceuticals (INFIQ) | 0.4 | $1.5M | 459k | 3.23 | |
| Kura Oncology (KURA) | 0.3 | $1.5M | 52k | 28.26 | |
| Conformis | 0.3 | $1.3M | 1.3M | 0.99 | |
| Syndax Pharmaceuticals (SNDX) | 0.3 | $1.3M | 58k | 22.37 | |
| Alpine Immune Sciences | 0.3 | $1.2M | 113k | 10.60 | |
| Larimar Therapeutics (LRMR) | 0.3 | $1.2M | 81k | 14.61 | |
| Turning Point Therapeutics I | 0.2 | $994k | 11k | 94.59 | |
| Otonomy | 0.2 | $993k | 390k | 2.55 | |
| Rigel Pharmaceuticals Com New | 0.2 | $942k | 276k | 3.42 | |
| Genfit S A Ads (GNFT) | 0.2 | $871k | 189k | 4.62 | |
| Theravance Biopharma (TBPH) | 0.2 | $840k | 41k | 20.41 | |
| Inogen (INGN) | 0.2 | $788k | 15k | 52.53 | |
| Scynexis Com New (SCYX) | 0.2 | $714k | 90k | 7.94 | |
| Masimo Corporation (MASI) | 0.2 | $689k | 3.0k | 229.67 | |
| Madrigal Pharmaceuticals (MDGL) | 0.2 | $655k | 5.6k | 116.96 | |
| Nextcure (NXTC) | 0.2 | $651k | 65k | 10.02 | |
| Spectrum Pharmaceuticals | 0.2 | $644k | 198k | 3.26 | |
| X4 Pharmaceuticals (XFOR) | 0.1 | $602k | 70k | 8.61 | |
| Iveric Bio | 0.1 | $556k | 90k | 6.18 | |
| Radius Health Com New | 0.1 | $302k | 15k | 20.83 | |
| Ngm Biopharmaceuticals | 0.1 | $291k | 10k | 29.10 | |
| Scpharmaceuticals (SCPH) | 0.1 | $259k | 39k | 6.66 | |
| Lineage Cell Therapeutics In (LCTX) | 0.0 | $177k | 75k | 2.35 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.0 | $153k | 18k | 8.34 | |
| Connect Biopharma Hldgs Ads (CNTB) | 0.0 | $148k | 8.0k | 18.50 |
